Forbion European Acquisition Corp. (NASDAQ:FRBN) Stock Position Lifted by Radcliffe Capital Management L.P.
Radcliffe Capital Management L.P. grew its holdings in Forbion European Acquisition Corp. (NASDAQ:FRBN – Get Rating) by 46.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 373,874 shares of the company’s stock after acquiring an additional 118,363 shares during the period. Radcliffe Capital Management L.P. owned 2.36% of Forbion European Acquisition worth $3,862,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in FRBN. Glazer Capital LLC acquired a new stake in shares of Forbion European Acquisition in the first quarter worth $156,000. UBS Group AG acquired a new position in Forbion European Acquisition during the 1st quarter valued at $249,000. Prelude Capital Management LLC acquired a new position in Forbion European Acquisition during the 1st quarter valued at $508,000. JPMorgan Chase & Co. acquired a new position in Forbion European Acquisition during the 1st quarter valued at $654,000. Finally, Basso Capital Management L.P. acquired a new position in Forbion European Acquisition during the 1st quarter valued at $1,995,000. 55.30% of the stock is owned by institutional investors.
Forbion European Acquisition Price Performance
NASDAQ:FRBN traded up $0.02 during trading hours on Friday, hitting $10.67. 104 shares of the company traded hands, compared to its average volume of 84,576. Forbion European Acquisition Corp. has a twelve month low of $9.94 and a twelve month high of $10.90. The firm has a 50-day moving average of $10.56 and a 200 day moving average of $10.42.
Forbion European Acquisition Profile
Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe.
Recommended Stories
Want to see what other hedge funds are holding FRBN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Forbion European Acquisition Corp. (NASDAQ:FRBN – Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Forbion European Acquisition, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Forbion European Acquisition wasn’t on the list.
While Forbion European Acquisition currently has a “hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
